Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Department of HIV, Hepatitis and STI, World Health Organization (WHO), Geneva, Switzerland.
PLoS One. 2022 May 4;17(5):e0263550. doi: 10.1371/journal.pone.0263550. eCollection 2022.
In 2016, WHO launched the Global Health Sector Strategy on STIs, 2016-2021 (GHSS) to provide guidance and benchmarks for country achievement by 2020 and four global targets for achievement by 2030.
A country survey jointly developed by experienced technical personnel at WHO Headquarters (HQ) and WHO regional offices was reviewed and distributed by WHO regional advisors to 194 WHO Member States in September-March 2020. The survey sought to assess implementation and prioritization of STI policy, surveillance, service delivery, commodity availability, and surveillance based on targets of the GHSS.
A majority (58%, 112/194) of countries returned a completed survey reflecting current (2019) STI activities. The regions with the highest survey completion rates were South-East Asia Region (91%, 10/11), Region of the Americas (71%, 25/35) and Western Pacific Region (67%, 18/27). Having a national STI strategy was reported by 64% (72/112) and performing STI surveillance activities by 88% (97/110) of reporting countries. Availability of STI services within primary health clinics was reported by 88% of countries (99/112); within HIV clinics by 92% (103/112), and within reproductive health services by 85% (95/112). Existence of a national strategy to eliminate mother-to-child transmission of HIV and syphilis (EMTCT) was reported by 70% of countries (78/112). Antimicrobial resistance (AMR) monitoring for gonococcal infection (gonorrhoea) was reported by 64% (57/89) of reporting countries with this laboratory capacity. Inclusion of HPV vaccine for young women in the national immunization schedule was reported by 59% (65/110) and availability of cervical cancer screening was reported by 91% (95/104). Stockouts of STI medicines, primarily benzathine penicillin, within the prior four years were reported by 34% (37/110) of countries.
Mechanisms to support improvements to STI service delivery through national-level policy, commitment, programming and surveillance are needed to operationalize, accelerate and monitor progress towards achievement of the 2030 global STI strategy targets.
2016 年,世卫组织发布了 2016-2021 年全球性传播感染卫生部门战略(全球卫生部门性传播感染战略,简称 GHSS),为各国在 2020 年实现目标提供了指导和基准,并为 2030 年实现四项全球目标制定了具体指标。
世卫组织总部(总部)和世卫组织区域办事处的经验丰富的技术人员共同制定了一份国家调查,并于 2020 年 9 月至 3 月期间由世卫组织区域顾问分发给 194 个世卫组织会员国。该调查旨在评估 STI 政策、监测、服务提供、商品供应以及基于 GHSS 目标的监测方面的实施和优先事项。
大多数(58%,112/194)国家返回了一份反映当前(2019 年)性传播感染活动的完整调查。完成率最高的地区是东南亚区域(91%,10/11)、美洲区域(71%,25/35)和西太平洋区域(67%,18/27)。有 64%(72/112)的报告国报告了国家性传播感染战略,88%(97/110)的报告国开展了性传播感染监测活动。88%(99/112)的国家报告在初级保健诊所提供性传播感染服务;92%(103/112)的国家在艾滋病毒诊所提供服务;85%(95/112)的国家在生殖健康服务中提供服务。70%(78/112)的国家报告了消除母婴传播艾滋病毒和梅毒(艾滋病毒和梅毒母婴传播消除)的国家战略。64%(57/89)有此实验室能力的报告国报告了淋病(淋病)的抗菌药物耐药性(AMR)监测。59%(65/110)的报告国将 HPV 疫苗纳入年轻女性国家免疫计划,91%(95/104)的报告国提供宫颈癌筛查。34%(37/110)的国家报告在过去四年中 STI 药物(主要是苄星青霉素)出现库存短缺。
需要通过国家级别的政策、承诺、规划和监测机制,支持改善性传播感染服务提供,以落实、加速和监测实现 2030 年全球性传播感染战略目标的进展。